Christopher C Conlin1, Christine H Feng2, Leonardino A Digma2, Ana E Rodriguez-Soto1, Joshua M Kuperman1, Dominic Holland3, Rebecca Rakow-Penner1, Tyler M Seibert1,2,4, Anders M Dale1,3,5, and Michael E Hahn1
1Department of Radiology, UC San Diego School of Medicine, La Jolla, CA, United States, 2Department of Radiation Medicine and Applied Sciences, UC San Diego School of Medicine, La Jolla, CA, United States, 3Department of Neurosciences, UC San Diego School of Medicine, La Jolla, CA, United States, 4Department of Bioengineering, UC San Diego Jacobs School of Engineering, La Jolla, CA, United States, 5Halıcıoğlu Data Science Institute, UC San Diego, La Jolla, CA, United States
Synopsis
Multicompartmental
diffusion modeling shows promise for overcoming the limitations of conventional
DWI methods and may help to improve the clinical evaluation of prostate-cancer
bone involvement. In
this study, we applied multicompartmental modeling to develop an empirical tissue
classifier for identifying bone lesions in whole-body DWI. The proposed classifier relates signal contributions
from model compartments with lower diffusion coefficients to the likelihood
that such contributions are from cancerous tissue. This approach proved effective
for detecting metastatic lesions in whole-body DWI data, considerably outperforming
a classifier based on conventional ADC values.
Motivation
Whole-body
diffusion-weighted imaging (DWI) is a promising approach for detecting prostate-cancer
bone metastases.1 Bone
lesions are typically identified qualitatively as hyperintense regions on DWI
and can be quantitatively examined by computing the apparent diffusion
coefficient (ADC).2 However,
normal tissues with high signal on DWI can impede lesion detection, and interpretation
of ADC values is confounded by numerous physiological factors.3
Multicompartmental modeling of the DWI signal is an effective approach for
overcoming these obstacles4 that
could improve the detection of metastases. In this study, we applied multicompartmental
modeling to develop an empirical tissue classifier for identifying bone lesions
in whole-body DWI.Methods
This prospective study included 30
patients with prostate cancer who underwent an extended whole-body MRI
examination in addition to routine clinical imaging. Standard-of-care
evaluation identified 107 bone lesions in 25 of these patients.
Whole-body MRI acquisition
MR imaging was performed on a 3T clinical
scanner (Discovery MR750; GE Healthcare). Five stations were imaged for each
patient, corresponding roughly to the head, chest, abdomen, pelvis, and thighs.
At each station, an axial volume of multi-shell diffusion data was acquired
using 4 b-values: 0, 500, 1000, and 2000 s/mm2, sampled at 1, 6, 6,
and 12 unique diffusion-encoding gradient directions, respectively (default
tensor, TR: 4750ms, TE: 75ms, matrix: 80×80 resampled to 128×128, FOV: 400mm,
slices: 46, slice thickness: 6mm). For anatomical reference, a high resolution
T2-weighted volume was also acquired at each station with scan-coverage
identical to that of the multi-shell DWI volume (TR: 1350ms, TE: 113ms, matrix:
384×224 resampled to 512×512, FOV: 400mm, slices: 46, slice thickness: 6mm).
MRI post-processing
Each multi-shell DWI volume was first
corrected for distortions due to B0-inhomogeneity, gradient nonlinearity, and
eddy currents.5 The signal intensity
of each DWI volume was corrected to account for noise.6 Isotropic diffusion
was assumed, so directional DWI volumes at each b-value were averaged.
Conventional ADC maps were computed by fitting the DWI data to a
monoexponential signal model.7
Regions of interest (ROIs) were defined on
DWI volumes over each of the identified bone lesions. In the 5 patients without
metastases, control ROIs were defined over the entire body excluding the head.
Multicompartmental modeling
Restriction spectrum imaging (RSI) is a
multicompartmental modeling framework for DWI. A previous study (see companion
abstract #2625) determined an optimal RSI model for
describing whole-body diffusion data:
$$S(b)=\sum_{i=1}^{4}C_ie^{-bD_i}$$
where S(b) denotes the measured DWI signal at a particular
b-value, Ci describes the compartmental signal contributions to be computed
via model-fitting, and Di refers to the compartmental diffusion
coefficients which are fixed for each of the 4 tissue compartments (to 0,
1.2e-3, 2.9e-3, and >3.0e-2mm2/s, respectively).
Signal-contribution (Ci) maps were computed for each patient by
fitting this model to the signal-vs-b-value curve from each voxel.4
Tissue classifier development
Previous studies have shown that diffusion signal
in tumors is enriched in the two model compartments with lowest diffusion
coefficient, C1 and C2.4,8,9 To determine how C1 and C2
vary between cancerous and normal tissue, two joint histograms were computed:
one recording the C1 and C2 signal-contribution of all
voxels within the bone-lesion ROIs, and another from all voxels within the
whole-body control ROIs. Normalizing these histograms by the total signal yielded
joint C1,C2 probability density functions (PDFs) for
lesions and normal tissue. Normalizing the lesion PDF by the sum of the lesion
and control PDFs generated a posterior-probability distribution for lesion
signal, which can serve as a lookup table relating a voxel’s C1 and
C2 measurements to the likelihood it contains cancerous tissue. This
lookup table was used to compute voxel-wise maps of cancer likelihood from the
C1 and C2 signal-contribution maps of all patients.
Tissue classifier performance
Leave-one-out cross validation at the patient level was used
to assess the performance of the RSI-derived tissue classifier. Likelihood
values and class labels (positive for voxels within lesion ROIs and negative
for the rest of the FOV) were used to generate a receiver operating
characteristic (ROC) curve. For comparison, an ROC curve was similarly
generated using ADC values. Area under the ROC curve (AUC) and false-positive
rate at 80% sensitivity (FPR80) were recorded for both classifiers.
Results
Example RSI signal-contribution
maps are shown in Figure 1 for a patient with bone lesions. Figure 2 shows the
joint C1,C2 PDFs for normal tissue and bone lesions, alongside
the lookup table of cancer-likelihood values derived from these PDFs. A voxel-wise
cancer likelihood map is shown in Figure 3 for comparison against conventional
MR images. Figure 4 illustrates that a tissue classifier based on these
likelihood values can more accurately identify metastatic lesions than one
based on conventional ADC values.Discussion
Multicompartmental analysis
of diffusion signal from prostate-cancer bone lesions enabled development of an
empirical signal classifier for identifying cancerous tissue in DWI data. This
classifier relates signal contributions from model compartments with lower
diffusion coefficients to the likelihood that such contributions are from
cancerous tissue. This approach considerably outperformed a classifier based on
conventional ADC values and could potentially help to increase the accuracy of whole-body
cancer screening.Acknowledgements
Funding provided by:
Department of Defense Congressionally Directed Medical Research Program. Grant Number: DoD W81XWH‐17‐1‐0618
Prostate Cancer Foundation
National Institute of Biomedical Imaging and Bioengineering. Grant Number: K08 EB026503
References
1. Padhani AR, Lecouvet FE, Tunariu N, et al.:
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines
for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance
Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate
Cancer. Eur Urol 2017; 71:81–92.
2. Pricolo P, Ancona E, Summers P, et al.: Whole-body
magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and
Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between
readers of different expertise levels. Cancer Imaging 2020; 20:77.
3. Panagiotaki E, Chan RW, Dikaios N, et al.:
Microstructural Characterization of Normal and Malignant Human Prostate Tissue
With Vascular, Extracellular, and Restricted Diffusion for Cytometry in Tumours
Magnetic Resonance Imaging. Invest Radiol 2015; 50:218.
4. Conlin CC, Feng CH, Rodriguez‐Soto
AE, et al.: Improved Characterization of Diffusion in Normal and Cancerous
Prostate Tissue Through Optimization of Multicompartmental Signal Models. J
Magn Reson Imaging (Early View).
5. Holland D, Kuperman JM, Dale AM: Efficient
correction of inhomogeneous static magnetic field-induced distortion in Echo
Planar Imaging. NeuroImage 2010; 50:175–183.
6. Karunamuni RA, Kuperman J, Seibert TM, et al.:
Relationship between kurtosis and bi-exponential characterization of high
b-value diffusion-weighted imaging: application to prostate cancer. Acta
Radiol 2018; 59:1523–1529.
7. Vidić I, Egnell L, Jerome NP, et al.: Modeling the
diffusion-weighted imaging signal for breast lesions in the b = 200 to 3000
s/mm2 range: quality of fit and classification accuracy for different
representations. Magn Reson Med 2020; 84:1011–1023.
8. Feng CH, Conlin CC, Batra K, et al.: Voxel-level
Classification of Prostate Cancer Using a Four-Compartment Restriction Spectrum
Imaging Model. medRxiv 2020:2020.07.25.20162172.
9. Andreassen MMS, Rodríguez-Soto AE, Conlin CC,
et al.: Discrimination of breast cancer from healthy breast tissue using a
three-component diffusion-weighted MRI model. Clin Cancer Res 2020.